|
Reede, 30. August 2019 |
08:40-09:00 |
Registreerimine |
|
09:00 | KONVERENTSI AVAMINE Welcome by Prof. Andres Metspalu, Estonian Genome Foundation/University of Tartu, Estonia |
| Kristjan Vassil, Vice-Rector of Research, University of Tartu, Eesti |
| Toomas Asser, Rector, University of Tartu, Eesti |
|
09:10-10:30 |
AVASESSIOON (Chair: Prof. Andres Metspalu, University of Tartu) |
Peaesineja | Prof. Dan Roden, Vanderbilt University Medical Center, USA “Using large biobanks to advance an agenda for personalized medicine”
|
| Prof. Heidi Rehm, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA/ The Broad Institute of Harvard and MIT, Cambridge, MA, USA "Supporting Genomics in the Practice of Medicine" |
|
10:30-10:50 |
Kohvi / tee |
|
10:50-12:45 |
I SESSIOON Moving towards personal medicine (Chair: Prof. Lili Milani, University of Tartu) |
| Dr. Mathew Garnett, Wellcome Sanger Institute, UK “Functional genomics approaches to identify targetable dependencies in cancer cells” |
| Prof. Ole Andreassen, University of Oslo, Institute of Clinical Medicine, Norra “Predicting age of onset of complex diseases - precision medicine with clinical relevance” |
| Prof. Stefan Fröhling, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) Heidelberg, Saksamaa "Cross-Institutional Implementation of Comprehensive Genomic Analysis for Precision Oncology" |
|
12:45-13:55 |
Lõuna |
|
13:55-15:50 |
II SESSIOON Pharmacogenomics in personalized medicine (Chair: Dr. Tõnu Esko, University of Tartu) |
| Prof. Henk-Jan Guchelaar, Leiden University Medical Center, The Netherlands "The time for personalized medicine is now" |
| Prof. Lili Milani, Estonian Genome Center, Institute of Genomics, University of Tartu, Eesti "Pharmacogenetic studies in the Estonian Biobank" |
| Prof. Erik Eliasson, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Rootsi “Clinical uptake of pharmacogenetics at Karolinska” |
|
15:50-16:10 |
Kohvi / tee |
|
16:10-16:50 |
DISKUSSIOON “Genomics – Towards Improving Medicine” (moderated by Prof. Andres Metspalu) |
|
16:50-18:00 |
III SESSIOON Epigenetics and gene regulation (Chair: Prof. Pärt Peterson, University of Tartu) |
| Dr. Kerrin Small, King’s College London, UK "Regulation of gene expression across tissues, time and environment" |
| Dr. Vardhman Rakyan, Blizard Institute, University of London, UK "Mammalian ribosomal DNA as a molecular environmental sensor" |
|
20:00 | Õhtusöök (Dorpati Konverentsikeskuses) |
|
|
Laupäev, 31. August 2019 |
09:30-11:30 |
IV SESSIOON Host-Microbiome interactions (Chair: Dr. Elin Org, University of Tartu) |
| Prof. Peer Bork, EMBL, Heidelberg, Saksamaa "Tracing the invisible life in us and on the planet: The world of microbes" |
| Prof. Alexandra Zhernakova, University of Groningen, The Netherlands “The gut microbiome: interaction of genetics, environment, and diseases” |
| Prof. Harri Alenius, Karolinska Institute, Rootsi “Molecular basis for allergy development: Impact of the living environment on microbe-host interaction in immune homeostasis and its dysregulation” |
|
11:30-11:50 |
Kohvi / tee |
|
11:50-13:50 |
V SESSIOON Evolutionary aspects of genetic traits (Chair: Dr. Mait Metspalu, University of Tartu) |
| Prof. Iain Mathieson, University of Pennsylvania, USA "Polygenic scores for complex traits across time and populations" |
| Prof. Lluis Quintana-Murci, Institut Pasteur, Paris, Prantsusmaa "Unraveling the sources of diversity of immune response phenotypes through population immunology studies” |
| Dr. Carina Schlebusch, Evolutionary Biology Centre, Uppsala University, Rootsi "The genetic history of Africa based on modern and ancient DNA" |
|
13:50-15:00 |
Lõuna |
|
15:00-16:50 |
VI SESSIOON Complex interactions in metabolic diseases (Chair: Dr. Ana Rebane, University of Tartu) |
| Prof. Margit Mahlapuu, University of Gothenburg, Rootsi “STK25 -a Critical Determinant in Non-Alcoholic Fatty Liver Disease” |
| Prof. Frode Norheim, Faculty of Medicine, University of Oslo, Norra "Gene-by-sex and gene-by-diet interactions in obesity" |
| Dr. Gregory Michelotti, Metabolon Inc., USA “Metabolomics enhances understanding of genomic and metagenomic variation to provide novel insights into human health” |
|
16:50 | Konverentsi lõpetamine |
|